We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock

Delisted

AXLA was delisted on the 22nd of November, 2023.

32 hedge funds and large institutions have $58.3M invested in Axcella Health Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

3% less funds holding

Funds holding: 3332 (-1)

16% less capital invested

Capital invested by funds: $69.2M → $58.3M (-$10.8M)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

Holders
32
Holders Change
-1
Holders Change %
-3.03%
% of All Funds
0.55%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
3
Increased
6
Reduced
8
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$32.3M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$13.5M +$21.5K +405 +0.1%
HP
3
Harbourvest Partners
Massachusetts
$7.49M
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.31M +$4.04K +76 +0.2%
AG
5
Artal Group
Luxembourg
$1.22M
BlackRock
6
BlackRock
New York
$507K -$2.98K -56 -0.5%
BCM
7
Bridgeway Capital Management
Texas
$428K
Geode Capital Management
8
Geode Capital Management
Massachusetts
$360K +$1.22K +23 +0.3%
ZIM
9
Zacks Investment Management
Illinois
$203K
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$194K +$46.8K +880 +24%
Edgewood Management
11
Edgewood Management
Connecticut
$171K
State Street
12
State Street
Massachusetts
$132K
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$94K +$91.7K +1,725 +369%
Renaissance Technologies
14
Renaissance Technologies
New York
$92K -$4.04K -76 -3%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$75K
Thrivent Financial for Lutherans
16
Thrivent Financial for Lutherans
Minnesota
$67K +$73.3K +1,380 New
Northern Trust
17
Northern Trust
Illinois
$63K +$7.17K +135 +10%
CCB
18
Cutter & Co Brokerage
Missouri
$34K
Commonwealth Equity Services
19
Commonwealth Equity Services
Massachusetts
$34K +$42.5K +800 New
Charles Schwab
20
Charles Schwab
California
$32K
TC
21
TownSquare Capital
Utah
$20K
Citadel Advisors
22
Citadel Advisors
Florida
$19K -$3.14K -59 -12%
TRCT
23
Tower Research Capital (TRC)
New York
$18K -$13.7K -257 -38%
UBS Group
24
UBS Group
Switzerland
$5K -$5.16K -97 -44%
LC
25
Lindbrook Capital
California
$3K -$2.13K -40 -33%

AXLA Hedge Fund Activity: Q3 2022 in Review

32 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q3 2022, worth a combined $58.3M — down 16% from $69.2M a quarter earlier.

Fund positioning in AXLA was balanced in Q3 2022: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 8 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $91.7K. The largest seller was HighTower Advisors, exiting entirely with an estimated $22K sold.

  • 32 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q3 2022, down from 33 in Q2 2022.
  • Funds reported $58.3M of Axcella Health Inc. Common Stock stock for Q3 2022, down 16% quarter-over-quarter.
  • 3 funds opened new Axcella Health Inc. Common Stock positions in Q3 2022 and 3 closed out, a net change of 0 holders.
  • The largest Axcella Health Inc. Common Stock buyer in Q3 2022 was Susquehanna International Group, an estimated $91.7K added.
  • The largest Axcella Health Inc. Common Stock seller in Q3 2022 was HighTower Advisors, an estimated $22K sold.

Based on aggregated 13F filings for Q3 2022.